Back to Search
ALEXEI MALININ M.D.
M.D.
Hospitalist Physician
NPI: 1396931879IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
DOO69989(MD)
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
D69989(MD)
Education
OTHER
Class of 1992
Research & Publications (20)
Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors.
PMID 16893441·Int J Clin Pract·2006
6-review
Treatment with selective serotonin reuptake inhibitors for enhancing wound healing.
PMID 15193359·Med Hypotheses·2004
7-preclinical
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
PMID 16563469·Thromb Res·2007
3-trial
Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease.
PMID 12591106·Eur J Pharmacol·2003
3-trial
Platelet activation in patients with congestive heart failure: do we have enough evidence to consider clopidogrel?
PMID 12660660·Am Heart J·2003
6-review
[The express-method of obtaining protease ECP32, the unique instrument in actin investigations].
PMID 19371023·Tsitologiia·2009
8-other
Selective thromboxane inhibition after vascular protectant AGI-1067: results of assessment of lipoprotein profiles (ALPS) biomarkers in vitro and in vivo substudy.
PMID 18521540·J Thromb Thrombolysis·2009
4-observational
Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
PMID 18188512·J Thromb Thrombolysis·2009
4-observational
Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular disease.
PMID 18273042·J Hum Hypertens·2008
8-other
Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
PMID 18343263·Clin Ther·2008
4-observational
Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease.
PMID 17530178·J Thromb Thrombolysis·2008
8-other
Magnitude and time course of platelet inhibition with extended release dipyridamole with or without aspirin in healthy Japanese volunteers. The AGgrenox versus Aspirin Therapy Evaluation (AGATE-Japan).
PMID 18217142·Thromb Haemost·2008
4-observational
Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
PMID 18082496·Am Heart J·2008
4-observational
Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients.
PMID 18485150·Fundam Clin Pharmacol·2008
4-observational
Consistent platelet inhibition during long-term maintenance-dose clopidogrel therapy among 359 compliant outpatients with documented vascular disease.
PMID 17307414·Am Heart J·2007
8-other
Combination antiplatelet therapy with aspirin and clopidogrel: the role of antecedent and concomitant doses of aspirin. An analysis of 711 patients.
PMID 17264511·Cardiology·2007
4-observational
Does heart failure etiology, New York Heart Association class, or ejection fraction affect the ability of clopidogrel to inhibit heightened platelet activity?
PMID 17287623·Blood Coagul Fibrinolysis·2007
8-other
Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
PMID 16546241·Thromb Res·2007
8-other
AGI-1067, a novel vascular protectant, anti-inflammatory drug and mild antiplatelet agent for treatment of atherosclerosis.
PMID 17605642·Expert Rev Cardiovasc Ther·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7601 OSLER DR
TOWSON, MD 21204 - Phone
- (410) 427-2574
Quick Facts
- NPI
- 1396931879
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile